{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-161568","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2022-05-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.315511+00:00","generated_at":"2026-06-25T06:29:40.254935+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Kewaunee Scientific extends preferred equity purchase period by 30 days for CAI sale-leaseback","bullets":["Extended by 30 days the purchase period for preferred equity in CAI Investments Medical Products I Parent, LLC.","Extension relates to previously disclosed sale-leaseback of headquarters at 2700 West Front Street, Statesville, NC.","Extension granted in consideration for an extension fee; amount not disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-161568","json":"https://secwatch.observer/filing/0001193125-22-161568.json","markdown":"https://secwatch.observer/filing/0001193125-22-161568.md","text":"https://secwatch.observer/filing/0001193125-22-161568.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000119312522161568/0001193125-22-161568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000119312522161568/d345553d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T06:29:40.254935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}